全文获取类型
收费全文 | 1764篇 |
免费 | 109篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 6篇 |
妇产科学 | 1篇 |
基础医学 | 231篇 |
口腔科学 | 81篇 |
临床医学 | 61篇 |
内科学 | 480篇 |
皮肤病学 | 15篇 |
神经病学 | 16篇 |
特种医学 | 32篇 |
外科学 | 103篇 |
综合类 | 283篇 |
预防医学 | 45篇 |
眼科学 | 12篇 |
药学 | 464篇 |
中国医学 | 69篇 |
肿瘤学 | 17篇 |
出版年
2024年 | 4篇 |
2023年 | 23篇 |
2022年 | 40篇 |
2021年 | 128篇 |
2020年 | 38篇 |
2019年 | 48篇 |
2018年 | 51篇 |
2017年 | 43篇 |
2016年 | 34篇 |
2015年 | 87篇 |
2014年 | 96篇 |
2013年 | 100篇 |
2012年 | 94篇 |
2011年 | 81篇 |
2010年 | 88篇 |
2009年 | 75篇 |
2008年 | 72篇 |
2007年 | 56篇 |
2006年 | 61篇 |
2005年 | 70篇 |
2004年 | 60篇 |
2003年 | 48篇 |
2002年 | 42篇 |
2001年 | 33篇 |
2000年 | 35篇 |
1999年 | 25篇 |
1998年 | 27篇 |
1997年 | 27篇 |
1996年 | 27篇 |
1995年 | 28篇 |
1994年 | 28篇 |
1993年 | 26篇 |
1992年 | 25篇 |
1991年 | 46篇 |
1990年 | 12篇 |
1989年 | 27篇 |
1988年 | 16篇 |
1987年 | 16篇 |
1986年 | 15篇 |
1985年 | 11篇 |
1984年 | 18篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1981年 | 7篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1976年 | 2篇 |
1975年 | 2篇 |
排序方式: 共有1919条查询结果,搜索用时 15 毫秒
11.
Crystals of L-leucylglycylglycylglycine, LGGG (C12H22N4O5), grown from an ethanol-water solution, are orthorhombic, space groups P212121, with unit cell dimensions (at 22 ± 3°) a = 9.337(1), b = 10.995(1), c = 15.235(1)Å, v = 1563.4 Å3, Z = 4 with a density of Dobs= 1.29 g-cm-3 and Dcalc= 1.279 g°cm-3. The crystal structure was solved by the application of direct methods and refined to an R value of 0.029 for 1018 reflections with I ± 2s?. The molecule exists as a zwitterion in the crystal. The trans peptide backbone takes up a folded conformation at the middle glycylglycyl link accompanied by a significant nonplanarity up to Δω of 8° at the middle peptide and is relatively more extended at the two ends. The molecules are linked together intermolecularly in an infinite sequence of head to tail 1–4′ hydrogen bonds, as is typical of charged peptides. It is interesting to note that while glycylglycylglycine takes up an extended β-sheet conformation, addition of Leu to the N-terminal results in a bent conformation. 相似文献
12.
Summary An assay system for the measurement of the rate of Calcium Oxalate Monohydrate (COM) seed crystal growth in a metastable solution of calcium chloride and sodium oxalate containing traces of 14C-oxalic acid was used to assess the inhibitory activity of pyrophosphate (10–5 M-10–4 M), citrate (10–4 M-10–3 M) and urines of normal and pyridoxine deficient rats. Both pyrophosphate and citrate were strong inhibitors of COM crystal growth and caused a 50% decrease in crystal growth rate at 1.50×10–5 M and 2.85×10–4 M respectively. Normal rat urine strongly inhibited the COM crystal growth, while pyridoxine deficient animals showed a significant (p< 0.01) decrease in mean inhibitory activity as compared to pair-fed controls. A lowered urinary inhibitory potential accompanied with hyperoxaluria and hypercalciuria, which is known to be associated with pyridoxine deficiency, may be a contributory risk of calcium oxalate crystallization and stone formation. 相似文献
13.
LARBI EL-MASDOURI ANDR AUBRY GUY BOUSSARD MICHEL MARRAUD 《Chemical biology & drug design》1992,40(6):482-486
The similar conformations and interaction modes of Ac-DL-Leu-Nme2 and Ac-Δ-Leu-NMe2 molecules in the solid state allow the comparison of their geometrical parameters. The most evident variations are essentially restricted to the α,β-unsaturated side-chain which adopts the Z-disposition. The dimensions of the peptide backbone are much less sensitive to α,β-unsaturation, with a small shortening by 0.04 Å and 0.02 Å of the N-Cα and Cα-C′ bonds, respectively, and an increase by 6° of the N-Cα- C′ bond angle. The ethylenic and amide groups in the Δ-Leu derivative are far from coplanarity, and a significant electronic conjugation of the π-orbital is likely to be rejected. 相似文献
14.
M. M. Giraud-Guille 《Calcified tissue international》1988,42(3):167-180
Summary Ultrathin sections of decalcified human compact bone, observed by transmission electron microscopy, reveal that collagen fibrils
can be distributed in the form of a superimposed series of nested arcs. This characteristic pattern has never been interpreted
in previous works on compact bone structure. We demonstrate, by goniometric observations at the ultrastructural level, that
such series of nested arcs are a consequence of the “twisted plywood” architecture of collagen fibrils in the compact bone
matrix. In the same specimens, an “orthogonal plywood” disposition of collagen fibrils is also observed; a transition exists
between these two types of orders. We show that the “twisted plywood structure” accounts well for certain optical properties
of osteons, observed in polarizing microscopy, described as “intermediate osteons.” The particular geometry of collagen fibrils,
leading to nested arcs in oblique sections, is analogous to the distribution of molecules in certain liquid crystals (called
cholesteric liquid crystals). The principle of a liquid crystalline self-assembly of the collagen matrix in bone is therefore
discussed. 相似文献
15.
The crystal structure of a tripeptide, tryptophanyl-glycyl-glycine dihydrate (C15H18N4O4·2H2O, molecular weight = 354) has been determined. The crystals are orthorhombic, space group P212121 with a= 7.875 (1) A,b= 9.009(1), c= 24.307(1) and Z = 4. The final R-index is 0.058 for 1488 reflections ((sin θ/λ≤ 0.6 A?1) with I < 2σ(I). The molecule exists as a zwitterion, with terminal NH+3 and COO? groups. The peptide units are trans and nearly perpendicular to the plane of the carboxyl group. The backbone torsion angles are: ψ1= 132.7°, ω1= 174.2°, φ2 88.2°, ψ= 8.6°, ω2 - 179.8°, φ= - 85.2°, ψ31, = - 178.1°, ψ32 5.0°. For the sidechain of tryptophan, χ1= - 171.6°, χ2 101.0°. 相似文献
16.
The dipeptide, L-prolyl-L-isoleucine monohydrate (C11 H20N2O3· H2O, molecular weight 246.3) crystallizes in the monoclinic space group P21, with a = 6.601(3)Å, b = 5.413(3) Å, c = 19.128(6) Å, β= 98.1(1)°, Z = 2, Do = 1.20g·cm-3 and Dc = 1.208g·cm-3. The structure was solved by MULTAN–80 and refined to a final R-factor of 0.081 for 594 reflections measured on a Enraf Nonius CAD-4 diffractometer. The peptide linkage exists in the trans conformation. The pyrrolidine ring is disordered with two alternate envelope conformations for the Cγ atom. The values of the sidechain torsion angles are: χ11=– 63.6(17)°, χ12= 171.1(16)° and χ2=– 59.6(21)° for isoleucine (C-terminal). The crystal structure is stabilized by a three-dimensional network of N—H ? O, O—H ? O and C—H ? O hydrogen bonds. The dipeptide exists in the extended Conformation. 相似文献
17.
人眼调制传递函数自动测试装置 总被引:1,自引:0,他引:1
本文介绍一个用单片机控制的人眼视网膜-大脑系统调制传递函数测量装置,与传统方法不同,该装置调制对比度是利用电光晶体控制激光束强度的来达到的。该装置不但可以测量空间调制传递的函数,还可测量时-空调制传递函数,并以数据和曲线的形式打印输出。 相似文献
18.
本研究选择奇异变形杆菌和绿肿杆菌等作为实验体系,从群体发生发展过程的宏观表现上探讨了生物控制的时空表达及非线性问题。结果表明,杆菌发生过程的时相周期性可以表现为空间的波形靶图样,并具有分形的特征。实验结果表明,菌群在生长过程中的代谢产物是富含生物信息的控制中介机制。我们认为,生物系统局部存在着准平衡和准封闭的微生态环境,生物液晶的存在和相变是细菌群体发生过程的重要协同中介因素。 相似文献
19.
目的:测定(2S,4S,5S)-3,4-二甲基-5-苯基-2-对二甲氨基苯基恶唑烷的光谱和晶体结构。方法:X-射线晶体衍射法。结果:晶胞参数为a=60783(4),b=190042(3),c=143421(2),V=162433,Z=4,Fw=26828,计算得,Dc=1032g/cm3,结构偏离因子为R=0058,Rw=0053。结论:标题化合物属于正交晶系,空间群为P212121。 相似文献
20.
Proximal tubular cells were loaded for 10 s with [3H]para-aminohippurate ([3H]PAH) by microperfusing the peritubular capillaries with Ringer solution containing 0.05 mmol/l PAH. Immediately thereafter
[3H]PAH influx from cells into a column of equilibrium solution injected into the oil-filled tubular lumen was measured by re-aspirating
the fluid after 1–10 s of contact time. The rise of luminal PAH concentration within 2 s of contact time was almost linear,
reaching a luminal / capillary concentation ratio of 1.6 after 2 s and of 3.2 after 5 s. The 2-s PAH concentration ratio was
not changed when different manoeuvres were applied to depolarize proximal tubular cells. Also, the 2-s PAH concentration ratio
was not influenced by varying the luminal pH from 6.0 to 8.0 or the luminal Cl–concentration from zero to 134 mmol/l or when either 5 mmol/l urate or 25 mmol/l lactate was in the luminal perfusate. A decrease
in the 2-s PAH concentration ratio, i.e. trans-inhibition, was observed when 25 or 50 mmol/l HCO3
–(–50%) was in the luminal perfusate. Trans-inhibition was also seen with 5 mmol/l of the following substituted benzoates:
2-hydroxy-benzoate (–58%), 2-methoxy-benzoate (–46%), 2-hydroxy-benzoate-acetyl ester (–36%), 2-hydroxy-3,5-dinitro-benzoate
(–48%), 3,5-dichloro-benzoate (–49%), and 2,3,5-trichloro-benzoate (–45%). No effect was seen with benzoate, 3-hydroxy-benzoate,
2-chloro-benzoate, 2-nitro-benzoate, 2,5-dinitro-benzoate, 3-sulfamoyl-benzoate and 4-sulfamoyl-benzoate. However, analogues
of the latter two compounds possessing two additional side groups, such as furosemide and piretanide, or a hydrophobic moiety,
such as probenecid, were inhibitory (by –62, –41 and –49% respectively). Phenoxyacetate had no effect; however, it inhibited
if in addition it had three chloro groups, as in 2,4,5-trichlorophenoxyacetate (–71%) or a hydrophobic carbamoyl side group,
as in mersalylic acid (salyrgan, –75%). Benzene-sulfonate trans-inhibited (–33%), as did phenolsulfonphthalein (phenol red,
–39%) and sulfofluorescein (–55%). However, the trans-inhibitory effect of the corresponding carboxy-compounds was absent
(phenolphthalein) or weaker (fluorescein, –42%). The trans-inhibitory effect of the uricosurics ethacrynic acid (–53%), tienilic
acid (–55%) indacrinone (–72%) and benzbromarone (–42%) could be attributed to two chloro or bromo side groups on the benzene
ring. Other trans-inhibiting uricosuric substances were indomethacin (–42%), sulfinpyrazone (–38%), losartan (–80%) its metabolite
EXP 3174 (–55%), and AA 193 (–65%). These organic acids, with pKa values between 2.8 and 4.9, possess chloro and sulfin groups, as well as heterocyclic 5-ring and hydrophobic ring or chain
areas. No significant effect was seen with 5 mmol/l PAH, 2-oxo-glutarate, DIDS, cGMP, prostaglandin E2, cortisol, benzylamiloride, pyrazinoic acid and 25 mmol/l lactate. Our data indicate that in situ the secretory luminal PAH
transport proceeds in a non-rheogenic fashion, per exclusionem by anion exchange. The observed trans-inhibition of PAH secretion seems to correlate with the affinity for the luminal PAH
transporter and, for uricosuric substances, with their uricosuric potency.
Received: 15 October 1996 / Received after revision: 17 December 1996 / Accepted: 18 December 1996 相似文献